Phibro Animal Health (PAHC) Expected to Announce Quarterly Earnings on Wednesday

Phibro Animal Health (NASDAQ:PAHC) will likely be issuing its Q1 2027 results after the market closes on Wednesday, November 4th. Analysts expect Phibro Animal Health to announce earnings of $0.7830 per share and revenue of $382.42 million for the quarter. Phibro Animal Health has set its FY 2027 guidance at 3.410-3.590 EPS. Interested persons are encouraged to explore the company’s upcoming Q1 2027 earnings summary page for the latest details on the call scheduled for Thursday, November 5, 2026 at 9:00 AM ET.

Phibro Animal Health (NASDAQ:PAHC) last posted its earnings results on Wednesday, August 26th. The company reported $0.85 EPS for the quarter, topping analysts’ consensus estimates of $0.71 by $0.14. The firm had revenue of $396.75 million for the quarter, compared to analyst estimates of $381.18 million. On average, analysts expect Phibro Animal Health to post $3.49 EPS for the current fiscal year and $3.81 EPS for the next fiscal year.

Phibro Animal Health Price Performance

NASDAQ PAHC opened at $38.38 on Wednesday. The company’s fifty day simple moving average is $36.79 and its 200-day simple moving average is $41.13. Phibro Animal Health has a 52 week low of $28.25 and a 52 week high of $60.08.

Analyst Upgrades and Downgrades

Several equities research analysts recently issued reports on PAHC shares. Weiss Ratings reaffirmed a “hold (c+)” rating on shares of Phibro Animal Health in a research note on Friday, September 11th. Zacks Research raised shares of Phibro Animal Health from a “hold” rating to a “strong-buy” rating in a research report on Friday, September 18th. One investment analyst has rated the stock with a Strong Buy rating, one has issued a Buy rating and two have given a Hold rating to the company’s stock. Based on data from MarketBeat, the company presently has an average rating of “Moderate Buy” and an average price target of $47.67.

Phibro Animal Health Company Profile

Phibro Animal Health Corporation develops, manufactures and sells products designed to support the health, nutrition and productivity of food-producing animals. Its offerings include animal health products, vaccines, medicated feed additives, nutritional specialties and performance products used in livestock, poultry and aquaculture.

The company’s products are intended to help prevent and manage disease, improve animal well-being and support efficient food production. Phibro serves producers, veterinarians, feed manufacturers and distributors through a portfolio that includes pharmaceuticals, vaccines, mineral and nutritional supplements, and other feed and water solutions.

Phibro Animal Health markets its products internationally across a broad range of geographic regions, including North America, Latin America, Europe, Asia-Pacific and other global markets.